🇺🇸 FDA

Drug profile · INN

tedizolid phosphate

SIVEXTRO

approved J01XX11
US status
approved
Patents linked
0
News articles
0

Quick answer

tedizolid phosphate (SIVEXTRO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN tedizolid phosphate
Brand SIVEXTRO
Route ORAL
Formulation POWDER
ATC code J01XX11

Frequently asked questions

What is tedizolid phosphate?

tedizolid phosphate (SIVEXTRO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for tedizolid phosphate?

SIVEXTRO is a marketed brand name for tedizolid phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of tedizolid phosphate?

tedizolid phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.